• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERSECT ENT PROPEL SINUS IMPLANT; DRUG ELUTING SINUS STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERSECT ENT PROPEL SINUS IMPLANT; DRUG ELUTING SINUS STENT Back to Search Results
Model Number 70011
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Scarring (2061)
Event Type  Injury  
Manufacturer Narrative
Attempts were made to contact the physician to request additional details in regard to this event, no response was received.The physician indicated that the patient needs revision surgery; however, it is unknown at this time, whether the patient has had revision surgery or has received any other treatment.Middle turbinate lateralization is a condition that may occur post-sinus surgery and is not likely to cause any detrimental effect in patients.It may impair visualization of the sinus cavity or if more severe may obstruct nasal drainage increasing the chance of sinus infections, however will not impair breathing.Thus, it is not likely that mt lateralization will cause or contribute to permanent impairment of body function or permanent damage to a body structure.The implant is intended to be used in conjunction with standard post-ess care, patient management is at the physician's discretion.Due to the limited information the company is taking a conservative approach in reporting this event.(b)(6).The following is being provided as this device is a combination product: name: propel, dose, frequency & route used: (1) 370 ug implant, diagnosis for use: sinus surgery.Combination product: yes.
 
Event Description
The patient underwent endoscopic sinus surgery (ess) including bilateral total full ethmoidectomy, frontal sinusotomy, and inferior turbinate resection, resulting in a significant tissue removal.The sinus implant was placed in the ethmoid sinus bilaterally per instructions for use (ifu).Physician instructed the patient to routinely irrigate.No post-operative visits were scheduled.The patient returned to see the physician 15 days post-operatively.The physician reported that the implant was not present, and the middle turbinate (mt) had scared to the lateral nasal wall bilaterally.The implant might have prematurely migrated and been expelled.The patient has been set up for revision surgery.(refer to mfr report # 3010101669-2015-00005 for other implant).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROPEL SINUS IMPLANT
Type of Device
DRUG ELUTING SINUS STENT
Manufacturer (Section D)
INTERSECT ENT
menlo park CA
Manufacturer (Section G)
INTERSECT ENT
1555 adams dr
menlo park CA 94025
Manufacturer Contact
amy wolbeck
1555 adams dr
menlo park, CA 94025
6506412115
MDR Report Key5039788
MDR Text Key24516256
Report Number3010101669-2015-00004
Device Sequence Number1
Product Code OWO
UDI-Device IdentifierM927700110
UDI-Public+M927700110
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Report Date 08/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/09/2016
Device Model Number70011
Device Catalogue Number70011
Device Lot Number50409004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/28/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/09/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-